Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

Clinical trial NCT06529406 · RECRUITING

Trial details

NCT number: NCT06529406
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2024-07-29
Primary completion: 2028-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.